abstract |
Methods for the prevention and treatment of neurodegenerative diseases, particularly mononeuron diseases such as amyotrophic lateral sclerosis (ALS), as well as combined compositions and preparations for use in such methods are described. These methods include inhibition of CHEK2 in the central nervous system of a subject in need of such prevention or treatment. |